Weight and Body Mass Index Change After Switching to Integrase Inhibitors or Tenofovir Alafenamide Among Women Living with HIV

Weight and body mass index (BMI) change was assessed among women after switch to integrase inhibitors (INSTIs) and/or tenofovir alafenamide (TAF). From 2006 to 2019, 1,458 women living with HIV enrolled in the Women's Interagency HIV Study and on antiretroviral therapy (ART) with ≥1 study visit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:AIDS Res Hum Retroviruses
Autores principales: Lahiri, Cecile D., Xu, Yanxun, Wang, Kunbo, Alvarez, Jessica A., Sheth, Anandi N., O'Halloran, Jane, Spence, Amanda B., Tien, Phyllis, Gustafson, Deborah R., Milam, Joel, Fischl, Margaret A., Konkle-Parker, Deborah, Adimora, Adaora A., Sharma, Anjali, Weber, Kathleen M., Ofotokun, Igho, Rubin, Leah H.
Formato: Artigo
Lenguaje:Inglês
Publicado: Mary Ann Liebert, Inc., publishers 2021
Materias:
Epidemiology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8213005/
https://ncbi.nlm.nih.gov/pubmed/33231474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2020.0197
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares